Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 10

Novel treatments for osteoarthritis: a recent update

Authors Wu Y, Goh EL, Wang D, Ma S

Received 25 June 2018

Accepted for publication 18 July 2018

Published 4 October 2018 Volume 2018:10 Pages 135—140


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Professor Chuan-Ju Liu

Yong Wu,1,* En Lin Goh,2,* Dong Wang,3 Shaocheng Ma3

1Leicester Medical School, University of Leicester, Leicester, UK; 2Faculty of Medicine, Imperial College London, London, UK; 3Biomechanics Research Group, Imperial College London, London, UK

*These authors contributed equally to this work

Abstract: Osteoarthritis is the most prevalent chronic joint condition worldwide. The principles of osteoarthritis treatment are to alleviate pain and stiffness as well as maintain function, with current consensus guidelines recommending the use of a combination of conservative measures including physical therapy, analgesia, and surgical interventions such as arthroplasty. In recent years, several pharmacological therapies have emerged as potential alternatives. Although a disease-modifying osteoarthritis drug has yet to be identified, promising results have been reported in recent trials especially with serotonin–norepinephrine reuptake inhibitors, IL-1 antagonists, and antibodies to nerve growth factor. The present review aims to summarize and discuss the latest results of novel treatments for osteoarthritis and potential targets for future research.

Keywords: osteoarthritis, novel treatment, future therapy, review

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]